Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Flamingo Therapeutics Inc.

Headquarters: Leuven, Belgium
Year Founded: 2020
Status: Private

BioCentury | Sep 4, 2024
Management Tracks

Evers leaving Evotec as CBO 

Plus: C-suite changes at Dyne, and updates from Novocure, Amphista, reMYND, Belite Bio, Forward and more 
BioCentury | Apr 4, 2023
Management Tracks

Eyeing deals, Biogen names Keeney head of corporate development

Plus: Flamingo hires a new CMO, and updates from Arkuda and GeneDx
BioCentury | Mar 3, 2023
Finance

March 2 Quick Takes: MorphoSys laying off staff, ending preclinical work

Plus: Flamingo teaming up with Dynacure and updates from Debiopharm, Aldeyra, Checkpoint and more
BioCentury | Jan 9, 2023
Management Tracks

Sanofi’s Zehnder to lead CureVac

Plus: new CEOs at Novavax, Intergalactic, Evoq and Helsinn, and updates from ADARx, Acadia and more
Items per page:
1 - 4 of 4